In-depth Analysis- CRISPR/Cas9 Technology

In-depth Analysis- CRISPR/Cas9 Technology

There has been a ceaseless development in gene modification strategy beginning from restriction endonucleases, transgenic breeding, and RNAi advances to the currently engineered endonucleases. Over the last few decades, Gene editing took a new turn with the discovery of CRISPR and its variant Cas9. CRISPR not only gave a new image to gene editing but also raised the standards for new findings. The CRISPR and CRISPR-associated (Cas) genes market is expected to hit a whopping value of USD 4.09 billion by 2025. The influencing factors for the escalated growth of the CRISPR-Cas system are progressive gene therapy, disease prevalence, GM crops, grants/funding, etc.

The key players (Maximum filing) in CRISPR-Cas system-based genome editing are Broad Institute, MIT, Harvard College, Dupont, University of California, etc.

Key Coverage

  • The report studies the analysis and multidimensional technical categorization viz. patent filing trends, country-wise patents, etc.
  • Technology forecast & core technology visualizations, prosecution visualization, statistical analytics, citation & classification visualization, etc.
  • Comprehensive list of players (companies & research institute), emerging players, cross-domain companies & inventor visualizations.
  • White space analysis, competitor benchmarking
  • CRISPR: Strategic Analysis SWOT & PEST
  • CRISPR-Cas system-based genome editing global market over the forecast period 2016- 2025
  • CRISPR market segmentation by region, application, end user & product.
  • Industry movement partnerships, agreements, collaborations, expansions, acquisitions, and product & service launches in the market
  • Profiles of prominent companies along with their market share & product portfolio
  • Recent advances & development

Project Scope
The report studies CRISPR Technology in various below stated segments:

By Application

  • Agrisciences
  • Cellular & animal study
  • Food & Nutrition
  • Therapeutics
  • Detection/Diagnosis
  • Veterinary

By End User

  • Biotechnology & Pharma firms
  • Research Institutes

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

IeB offers tailored information as per client needs viz. additional company profiling (up to 10), partner identification, regions that are untapped, key strategies employed by the target companies for their sustenance in the studied field, etc.

our Experts